By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Approves Middle of the Night Sleeping Pill–Treatments Are Getting Specific–Is This Personalized Medicine?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > FDA Approves Middle of the Night Sleeping Pill–Treatments Are Getting Specific–Is This Personalized Medicine?
BusinessNews

FDA Approves Middle of the Night Sleeping Pill–Treatments Are Getting Specific–Is This Personalized Medicine?

BarbaraDuck
BarbaraDuck
Share
2 Min Read
SHARE

Ok so a little humor as you are only supposed to have this sleeping aid if you already have some sleep under your belt.  It’s a lower dose so that one does not get up and take another full dose is what I get from this one.

Ok so a little humor as you are only supposed to have this sleeping aid if you already have some sleep under your belt.  It’s a lower dose so that one does not get up and take another full dose is what I get from this one. image

The middle of the night is kind of funny actually as it’s just a lower dose pill, what they not stop at to market!  I would think one could take a lower dose if their issues I sleeping were not as drastic, right?  Also the way the article reads it assumes that you have already taken one full strength pill so this is safer than a double dose.  I’m not a bit sleeping pill person and have taken a few in my life but I hate the sleeping pill hang over so when I have those occasional nights, the half glass of wine for me still works well.  BD 

Federal health regulators say they have approved the first insomnia pill designed for people who wake up in the middle of the night and have trouble getting back to sleep.

Transcept Pharmaceuticals’ Intermezzo pill is a lower dose of the key ingredient in Ambien, the popular sleep medication first approved in 1992. FDA officials say the new pill offers a safer option than taking a second dose of zolpidem tartrate, the ingredient in Sanofi’s Ambien, to get back to sleep.

“With this lower dose there is less risk of a person having too much drug in the body upon waking, which can cause dangerous drowsiness and impair driving,” said Dr. Robert Temple, director for clinical science in FDA’s drug center.

 

More Read

get a first report on injury after an incident
What’s a First Report of Injury or Illness Form?
Myth Busters #6: Certificate of Need
How Do You Make Sure That a Supplement Is FDA Approved?
A Tale of Two Gowns: The Patient Experience
Why Blogging Can Do Wonders For Your Practice

TAGGED:FDAIntermezzopharmaceuticalssleeping pill
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

grief affects brain
How Grief Affects The Brain And Body
Infographics Mental Health
June 19, 2026
The Difference Between a Sustainable NP Practice and One That Burns Out in Three Years
The Difference Between a Sustainable NP Practice and One That Burns Out in Three Years
Career Nursing
June 19, 2026
medical facilites
Understanding Navigation Stress In Medical Facilities
Health Infographics
June 19, 2026
appointment ready
Appointment Ready: A Practical Patient Intake Preparation Guide
Hospital Administration Infographics
June 19, 2026

You Might also Like

Hospital-Website-Design-Healthcare-Marketing-Digital-Marketing
BusinessHospital Administration

Attracting the Attention of the Future Patient: 4 Elements to Consider When Designing Your Hospital’s Website

July 30, 2015

Medicare Data Access Provides Payment Transparency

April 11, 2011

Open Science Champions: NCBI Director, 16-Year-Old Researcher Among White House Honorees

June 28, 2013
siipc14
BusinesseHealthHealth ReformMobile HealthPublic Health

Keeping Patients in the Dark

July 6, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?